Optical Prism February 2020 | Page 11

EYE FOCUS | COVER STORY
MGD treatment system
OVER 6 MILLION PEOPLE
IN CANADA SUFFER
FROM DRY EYE. 1
86% OF DRY EYE PATIENTS HAVE SIGNS OF
MEIBOMIAN GLAND DYSFUNCTION (MGD). 2
TAKE CONTROL AND TREAT MGD WITH
CONFIDENCE. 3
For personalized, real dry eye relief, the iLUX®
device, with its advanced Smart Tip Patient
Interface, gives you results you can see.
Caffery et al. Prevalence of dry eye disease in Ontario, Canada: A population-based survey. The Ocular Surface. 2019:1-6
Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a
clinic-based patient cohort: a retrospective study. Cornea. 2012;31:472-478.
3.
Hardten DR, Schanzlin JD, Dishler JG, et al. Comparison of a Handheld Infrared Heating and Compression Device for
Treatment of Meibomian Gland Dysfunction to a Thermal Pulsation Device. Presented at the Annual Meeting of the
American Society of Cataract and Refractive Surgery (ASCRS); April 13-17, 2018; Washington, D.C.
1.
2.
© 2019 Alcon Inc. 07/19 CA-ILU-1900017
EYE FOCUS | February Digital 2020 11